Compare ORRF & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ORRF | CBLL |
|---|---|---|
| Founded | 1919 | 2014 |
| Country | United States | United States |
| Employees | N/A | 280 |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 699.5M | 750.1M |
| IPO Year | 1995 | N/A |
| Metric | ORRF | CBLL |
|---|---|---|
| Price | $39.70 | $18.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $42.00 | $23.20 |
| AVG Volume (30 Days) | 126.9K | ★ 262.3K |
| Earning Date | 04-21-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.29% | N/A |
| EPS Growth | ★ 182.43 | N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | ★ $37,144,000.00 | N/A |
| Revenue This Year | N/A | $29.57 |
| Revenue Next Year | $3.15 | $28.44 |
| P/E Ratio | $35.49 | ★ N/A |
| Revenue Growth | ★ 36.00 | N/A |
| 52 Week Low | $31.51 | $10.85 |
| 52 Week High | $40.72 | $24.33 |
| Indicator | ORRF | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 62.76 | 50.87 |
| Support Level | $34.95 | $17.11 |
| Resistance Level | $40.26 | $19.56 |
| Average True Range (ATR) | 1.19 | 0.82 |
| MACD | 0.11 | 0.05 |
| Stochastic Oscillator | 85.91 | 64.56 |
Orrstown Financial Services Inc is a financial holding company. Through its subsidiaries, it operates in the community banking segment and engages in lending activities, including commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending and deposit services, including checking, savings, time, and money market deposits. The Group also provides fiduciary, investment advisory, insurance, and brokerage services. It offers services to individuals, professionals, small businesses, and other enterprises across different locations in the United States through its branch network and client service centers.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.